Anaptysbio Inc (ANAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ANAB | BMY | AMGN | GILD | REGN |
| Company | Anaptysbio Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 37.23 | 49.89 | 337.03 | 84.39 | 1,149.66 |
| High | 39.50 | 50.04 | 338.70 | 84.65 | 1,165.85 |
| Low | 37.12 | 48.94 | 334.61 | 83.43 | 1,148.13 |
| Last | 37.53 | 49.02 | 335.95 | 83.90 | 1,150.19 |
| Change | +0.96 | -0.72 | +3.03 | +0.01 | +11.38 |
| % Change | +2.63% | -1.45% | +0.91% | +0.01% | +1.00% |
| Volume | 297,700 | 8,841,400 | 1,626,200 | 8,798,200 | 596,600 |
| 20-Day Average Volume | 256,250 | 8,610,180 | 1,760,685 | 6,694,930 | 420,385 |
| Previous Close | 36.57 | 49.74 | 332.92 | 83.89 | 1,138.81 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 37.09 | 49.09 | 329.59 | 80.07 | 1,165.51 |
| 20-Day Raw Stochastic | 49.87% | 55.24% | 84.75% | 89.62% | 37.72% |
| 20-Day Relative Strength | 55.60% | 54.18% | 57.67% | 71.87% | 52.90% |
| Weighted Alpha | +115.96 | -11.20 | +27.09 | +18.24 | +41.12 |
| Today's Opinion | 100% Buy | 56% Buy | 96% Buy | 88% Buy | 80% Buy |
| Previous Opinion | 88% Buy | 72% Buy | 88% Buy | 88% Buy | 80% Buy |
| Last Month's Opinion | 100% Buy | 40% Buy | 88% Buy | 56% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.01% since 09/12/24 | +1.62% since 09/12/24 | +1.78% since 09/12/24 | +0.89% since 09/12/24 | -1.23% since 09/12/24 |
| Low | 36.50 on 09/18/24 | 48.20 on 09/13/24 | 327.15 on 09/13/24 | 81.57 on 09/13/24 | 1,134.59 on 09/17/24 |
| High | 40.70 on 09/13/24 | 50.41 on 09/17/24 | 339.00 on 09/18/24 | 84.65 on 09/19/24 | 1,170.58 on 09/13/24 |
| 1-Month | |||||
| %Chg | +2.96% since 08/19/24 | -0.57% since 08/19/24 | +2.43% since 08/19/24 | +12.69% since 08/19/24 | -3.90% since 08/19/24 |
| Low | 34.23 on 08/20/24 | 46.88 on 08/22/24 | 319.00 on 09/06/24 | 74.34 on 08/20/24 | 1,113.24 on 09/11/24 |
| High | 40.70 on 09/13/24 | 50.75 on 09/04/24 | 339.00 on 09/18/24 | 84.89 on 09/12/24 | 1,211.20 on 08/27/24 |
| 3-Month | |||||
| %Chg | +63.96% since 06/18/24 | +20.12% since 06/18/24 | +9.79% since 06/18/24 | +32.86% since 06/18/24 | +10.69% since 06/18/24 |
| Low | 22.26 on 06/20/24 | 39.35 on 07/05/24 | 303.55 on 06/20/24 | 64.86 on 06/20/24 | 1,011.67 on 07/03/24 |
| High | 41.31 on 08/14/24 | 51.19 on 07/29/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 1,211.20 on 08/27/24 |
| 6-Month | |||||
| %Chg | +61.28% since 03/19/24 | -5.37% since 03/19/24 | +23.63% since 03/19/24 | +14.29% since 03/19/24 | +19.36% since 03/19/24 |
| Low | 18.49 on 04/25/24 | 39.35 on 07/05/24 | 260.68 on 04/19/24 | 62.07 on 05/31/24 | 875.22 on 04/26/24 |
| High | 41.31 on 08/14/24 | 54.47 on 03/28/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 1,211.20 on 08/27/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,025,282 | 99,368,440 | 180,215,344 | 104,527,072 | 126,734,816 |
| Shares Outstanding, K | 27,319 | 2,027,100 | 536,435 | 1,245,853 | 110,186 |
| Annual Sales | 17,160,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 13,117,200,000 |
| Annual Net Income | -163,620,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,953,600,000 |
| Last Quarter Sales | 10,970,000 | 12,201,000,000 | 8,388,000,000 | 6,954,000,000 | 3,547,100,000 |
| Last Quarter Net Income | -46,660,000 | 1,680,000,000 | 746,000,000 | 1,614,000,000 | 1,432,300,000 |
| 60-Month Beta | -0.29 | 0.46 | 0.61 | 0.18 | 0.12 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.71 on 08/05/24 | 2.07 on 07/26/24 | 4.97 on 08/06/24 | 2.01 on 08/08/24 | 11.56 on 08/01/24 |
| Latest Earnings Date | 11/07/24 | 10/31/24 | 10/29/24 | 11/05/24 | 11/07/24 |
| Most Recent Dividend | N/A | 0.600 on 07/05/24 | 2.250 on 08/16/24 | 0.770 on 09/13/24 | N/A |
| Next Ex-Dividends Date | N/A | 10/04/24 | 08/16/24 | 09/13/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 36.31 | 17.90 | 17.85 | 29.64 |